Brainsway (BWAY) Competitors $11.87 +0.15 (+1.28%) Closing price 08/5/2025 04:00 PM EasternExtended Trading$12.03 +0.16 (+1.35%) As of 04:04 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BWAY vs. KMTS, SIBN, IRMD, EMBC, BBNX, AXGN, AVNS, KIDS, CBLL, and BVSShould you be buying Brainsway stock or one of its competitors? The main competitors of Brainsway include Kestra Medical Technologies (KMTS), SiBone (SIBN), iRadimed (IRMD), Embecta (EMBC), Beta Bionics (BBNX), AxoGen (AXGN), AVANOS MEDICAL (AVNS), OrthoPediatrics (KIDS), CeriBell (CBLL), and Bioventus (BVS). These companies are all part of the "medical equipment" industry. Brainsway vs. Its Competitors Kestra Medical Technologies SiBone iRadimed Embecta Beta Bionics AxoGen AVANOS MEDICAL OrthoPediatrics CeriBell Bioventus Brainsway (NASDAQ:BWAY) and Kestra Medical Technologies (NASDAQ:KMTS) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, media sentiment, risk, institutional ownership, earnings, dividends and analyst recommendations. Which has preferable valuation & earnings, BWAY or KMTS? Brainsway has higher earnings, but lower revenue than Kestra Medical Technologies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBrainsway$41.02M5.47$2.92M$0.2059.35Kestra Medical Technologies$59.81M13.62-$113.81MN/AN/A Do analysts recommend BWAY or KMTS? Brainsway presently has a consensus target price of $14.25, suggesting a potential upside of 20.05%. Kestra Medical Technologies has a consensus target price of $27.33, suggesting a potential upside of 72.34%. Given Kestra Medical Technologies' higher possible upside, analysts clearly believe Kestra Medical Technologies is more favorable than Brainsway.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Brainsway 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Kestra Medical Technologies 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83 Do institutionals and insiders hold more shares of BWAY or KMTS? 30.1% of Brainsway shares are held by institutional investors. 19.0% of Brainsway shares are held by company insiders. Comparatively, 3.6% of Kestra Medical Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Is BWAY or KMTS more profitable? Brainsway has a net margin of 9.01% compared to Kestra Medical Technologies' net margin of 0.00%. Brainsway's return on equity of 7.35% beat Kestra Medical Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Brainsway9.01% 7.35% 4.72% Kestra Medical Technologies N/A N/A N/A Does the media favor BWAY or KMTS? In the previous week, Kestra Medical Technologies had 2 more articles in the media than Brainsway. MarketBeat recorded 4 mentions for Kestra Medical Technologies and 2 mentions for Brainsway. Kestra Medical Technologies' average media sentiment score of 1.24 beat Brainsway's score of 0.77 indicating that Kestra Medical Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Brainsway 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Kestra Medical Technologies 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryBrainsway beats Kestra Medical Technologies on 7 of the 13 factors compared between the two stocks. Get Brainsway News Delivered to You Automatically Sign up to receive the latest news and ratings for BWAY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BWAY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BWAY vs. The Competition Export to ExcelMetricBrainswayMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$221.48M$10.59B$5.59B$9.53BDividend YieldN/A2.00%4.73%4.14%P/E Ratio59.3519.2928.9123.88Price / Sales5.4727.93448.7998.82Price / Cash47.0022.1035.6858.35Price / Book3.593.888.165.60Net Income$2.92M$211.77M$3.25B$265.26M7 Day Performance1.02%1.29%1.15%-0.14%1 Month Performance-9.73%4.55%8.25%6.08%1 Year Performance72.28%-10.58%29.18%24.22% Brainsway Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BWAYBrainsway3.1067 of 5 stars$11.87+1.3%$14.25+20.1%+85.8%$221.48M$41.02M59.35120Upcoming EarningsKMTSKestra Medical Technologies1.5438 of 5 stars$16.50-0.3%$27.33+65.7%N/A$849.82M$59.81M0.00300Positive NewsSIBNSiBone4.0507 of 5 stars$17.60+2.0%$22.50+27.8%+14.0%$735.10M$167.18M-27.50350News CoverageEarnings ReportAnalyst ForecastGap DownIRMDiRadimed4.0791 of 5 stars$57.11+1.4%$72.00+26.1%+57.2%$716.11M$73.24M36.85110Dividend AnnouncementEMBCEmbecta4.7421 of 5 stars$11.33-3.4%$19.00+67.7%-29.8%$685.53M$1.12B12.592,100Positive NewsUpcoming EarningsBBNXBeta Bionics2.7173 of 5 stars$13.99-5.7%$23.44+67.6%N/A$643.41M$65.12M0.00294AXGNAxoGen2.3294 of 5 stars$12.99-2.8%$24.50+88.6%+76.0%$608.92M$187.34M-86.59450News CoverageGap UpHigh Trading VolumeAVNSAVANOS MEDICAL1.942 of 5 stars$12.02+0.1%N/A-56.5%$555.39M$687.80M-1.442,227Trending NewsEarnings ReportKIDSOrthoPediatrics3.9162 of 5 stars$22.39-1.6%$35.83+60.0%-30.5%$552.52M$204.73M-12.79200Trending NewsEarnings ReportCBLLCeriBell2.864 of 5 stars$14.96-1.1%$32.14+114.9%N/A$546.84M$65.44M0.00N/ANews CoverageEarnings ReportBVSBioventus1.7883 of 5 stars$6.53-0.6%N/AN/A$539.69M$573.28M-13.601,200 Related Companies and Tools Related Companies KMTS Alternatives SIBN Alternatives IRMD Alternatives EMBC Alternatives BBNX Alternatives AXGN Alternatives AVNS Alternatives KIDS Alternatives CBLL Alternatives BVS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BWAY) was last updated on 8/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredStrange twist to Bitcoin’s rallyThe #1 crypto to buy today Better than Bitcoin? (top crypto for less than $1) Over the past 15 years, B...Stansberry Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Brainsway Ltd. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Brainsway With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BWAY Stock Alerts